Tower Research Capital LLC (Trc) Igm Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,628 shares of IGMS stock, worth $62,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,628

Previous 258 1306.2%

Holding current value

$62,619

Previous $2,000 1100.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.51 - $11.47 $21,938 - $38,653	3,370 Added 1306.2%	3,628 $24,000
Q1 2024 May 15, 2024	SELL	$8.68 - $17.36 $11,145 - $22,290	-1,284 Reduced 83.27%	258 $2,000
Q4 2023 Feb 13, 2024	SELL	$3.94 - $8.79 $5,342 - $11,919	-1,356 Reduced 46.79%	1,542 $12,000
Q3 2023 Nov 14, 2023	BUY	$6.66 - $10.64 $2,544 - $4,064	382 Added 15.18%	2,898 $24,000
Q2 2023 Aug 14, 2023	SELL	$8.86 - $14.0 $31,949 - $50,484	-3,606 Reduced 58.9%	2,516 $23,000
Q1 2023 May 09, 2023	BUY	$13.74 - $25.76 $75,899 - $142,298	5,524 Added 923.75%	6,122 $84,000
Q4 2022 Feb 10, 2023	SELL	$15.45 - $26.02 $21,954 - $36,974	-1,421 Reduced 70.38%	598 $10,000
Q3 2022 Nov 10, 2022	SELL	$15.42 - $27.01 $43,684 - $76,519	-2,833 Reduced 58.39%	2,019 $46,000
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $79,235 - $152,260	-5,971 Reduced 55.17%	4,852 $87,000
Q1 2022 May 12, 2022	BUY	$13.42 - $29.73 $117,237 - $259,721	8,736 Added 418.59%	10,823 $289,000
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $35,894 - $86,373	1,301 Added 165.52%	2,087 $61,000
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $4,340 - $5,982	-66 Reduced 7.75%	786 $52,000
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $43,542 - $72,546	-751 Reduced 46.85%	852 $71,000
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $46,657 - $79,041	652 Added 68.56%	1,603 $123,000
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $14,365 - $34,854	-303 Reduced 24.16%	951 $84,000
Q3 2020 Nov 16, 2020	SELL	$43.0 - $84.01 $73,100 - $142,817	-1,700 Reduced 57.55%	1,254 $92,000
Q2 2020 Aug 13, 2020	BUY	$51.3 - $75.21 $141,177 - $206,977	2,752 Added 1362.38%	2,954 $216,000
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $6,365 - $14,897	202 New	202 $11,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

21.4M

Call Options Held

39.5K

Put Options Held

16.5K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Igm Biosciences, Inc. Transaction History